AceAge, a healthcare technology company with its innovative medication dispenser, Karie, announced that it has closed a CA $5 million Series A financing round led by Longliv Ventures, with the participation of a fund managed by the Bloom Burton Investment Group. Karie allows users with complex medication regimes to take their medication independently.
Molly Shoichet named one of the Top 100 Most Powerful Women in Canada
Molly Shoichet, professor of chemical engineering and applied chemistry and Canada Research Chair in Tissue Engineering at the University of Toronto, has been named one of the Top 100 most powerful women in Canada by Women’s Executive Network (WXN). The list recognizes the country’s highest achieving female leaders in the private, public and not-for-profit sectors.
Spiderwort included in Praxis SCI Incubate 2020
Spiderwort is included in the inaugural cohort of Praxis SCI Incubate, a six month program geared towards pre-prototype projects with an innovation to transform the lives of people living with spinal cord injury (SCI).
FDA grants a Breakthrough Device Designation for Spiderwort Spinal Cord Technology
Spiderwort Inc., a Canadian medical device company developing innovative biomaterials for regenerative medicine, is pleased to announce that the U.S. Food and Drug Administration (FDA) has designated CelluBridgeTM, Spiderwort’s Spinal Cord Scaffold Implant, as a “Breakthrough Device”.
Intellijoint Surgical Ranks Number 1 on Deloitte’s Technology Fast 50™ Companies List
Intellijoint Surgical is ranked first on Deloitte Technology Fast 50™ list with a 19,311 percent revenue growth from 2016 to 2019. The program recognizes Canada’s 50 fastest-growing technology companies with the highest revenue-growth percentage over the past four years.
ACTO acquires CoHealth to open new frontier in patient education
CoHealth has been acquired by ACTO, the Omnichannel Education and Engagement Platform for Life Sciences. CoHealth is a mobile application that provides trusted resources for patients and caregivers, enabling them to effectively navigate through and coordinate their care journey.
Dr. Molly Shoichet wins Canada's top science prize
The Natural Sciences and Engineering Research Council of Canada has announced that Molly Shoichet, professor of chemical engineering and applied chemistry and Canada Research Chair in Tissue Engineering at the University of Toronto is this year's recipient of the $1 million Gerhard Herzberg Canada Gold Medal for her work designing gels that mimic human tissues.
University of Waterloo to launch new $35 million medtech innovation centre
The University of Waterloo and the City of Kitchener will officially partner to bring a med-tech centre to the city. The facility will be home to health innovation and medical technology including a wet lab for chemical/materials science, four biosafety labs, and universal product development space.
MacroHealth raises $54 million Series A
Healthtech startup MacroHealth, which offers a platform that optimizes the buying and selling of health services, has raised a $54 million CAD Series A round of financing. Participants in the Series A round included NewSpring Capital, Providence Ventures and Triple Tree Capital Partners.
Notch Therapeutics appoints Kamran Alam as CFO and Gregory Block as SVP, Corporate Development
Notch Therapeutics Inc., a cell therapy company with a proprietary platform for generating renewable stem cell-derived T cell therapies for cancer and other immune disorders, announced today the appointment of Kamran Alam as Executive Vice President, Finance and Chief Financial Officer and Gregory Block as Senior Vice President, Corporate Development, effective immediately.
Joint Pathology Center selects Huron Digital Pathology’s image search engine
Huron Digital Pathology announced that the Joint Pathology Center (JPC), the premier pathology reference center for the United States federal government and part of the US Defense Health Agency, has selected Huron’s artificial intelligence-enabled LagottoTM image search engine to index and search JPC’s growing digital image archive, as part of JPC’s digital pathology modernization efforts.
Updates on Canada’s New Substances Notifications Regulations (Organisms)
To help protect the health of Canadians and the environment, the New Substances Notification Regulations (Organisms) were created to ensure the proper assessment of new living organisms introduced into the Canadian marketplace. If you import or manufacture a new substance or a product containing a new substance then you must ensure that these new substances have been assessed for potential risk to the environment and human health, as required by the New Substances Notification Regulations (Organisms). Download the fact sheet and sign up for updates to these regulations.
AmacaThera announces Phase 1 clinical trial for non-opioid, post-operative pain management
AmacaThera Inc. announce approval from Health Canada to proceed to a Phase 1 clinical trial with its lead asset, a long-acting anesthetic formulation for the treatment of post-surgical pain.
Microbix announces $1.45 million grant for production of critical test reagents
Microbix has announced a $1.45 million grant from the Ontario Together Fund (OTF) of the Ministry of Economic Development, Job Creation and Trade which will cover 50% of the cost to automate the production of the quantities of viral transport media needed for Ontario’s nucleic-acid testing for COVID-19.
Ironstone Product Development named one of Canada's fastest-growing companies
IPD has been listed in the top 100 of Canada’s fastest growing companies by both Maclean’s and Canadian Business magazines. For the past 5 years, IPD has expanded from providing regulatory consulting services to offering a full suite of medical device development services including clinical study design, QMS design and support, and turn-key product development.
League and Loblaw bring next-generation digital health platform to customers
League has partnered with Loblaws Inc. to develop the PC Health app, a new personalized digital health app designed to improve how Canadians access and navigate healthcare. The new partnership aims to provide a new personalized “front door” to healthcare—one place for Canadians to manage their health and get support.
Lazaridis Scaleup program announces new cohort including ProteinQure and BlueDot
Thirteen Canadian tech startups have been accepted into the Lazaridis Institute’s ScaleUp Program, representing the program’s largest cohort yet. This year’s cohort includes health science companies, ProteinQure and BlueDot.
Apply for the Canada-Chicago Mentoring Program
Canadian innovators and entrepreneurs in health science are invited to apply for the Canada-Chicago Mentoring Program (C2MP).
The C2MP provides opportunities to access coaching and mentoring, improve understanding of US market access, and build your network of contacts in the Chicago area.
Deadline to apply: November 13
For questions, please contact Julien Rosan at chcgo-td@international.gc.ca
RetiSpec partners with Gentex to commercialize Alzheimer's disease detection technology
RetiSpec Inc. announced today that it is partnering with Gentex Corporation to engineer, manufacture and commercialize technology for the early detection of Alzheimer's disease. By harnessing hyperspectral imagery, RetiSpec's patented technology allows for the rapid, simple and cost-effective identification of Alzheimer's biomarkers years before the emergence of clinical symptoms.
VoxNeuro signs agreement with UHN to launch concussion study
VoxNeuro announced it has signed an agreement with The Kite Research Institute, the research arm of Toronto Rehab – University Health Network, to complete a multi-month study at The Hull-Ellis Concussion and Research Clinic. The study, launched September 30, 2020, will follow concussed patients through their treatment and recovery.